MODULATION OF ENDOTHELIAL LIPASE EXPRESSION

Details for Australian Patent Application No. 2003300862 (hide)

Owner ISIS PHARMACEUTICALS INC.

Inventors DOBIE, Kenneth, W.

Pub. Number AU-A-2003300862

PCT Number PCT/US2003/0394

PCT Pub. Number WO2004/055162

Priority 10/319,915 12.12.02 US

Filing date 11 December 2003

Wipo publication date 9 July 2004

Event Publications

27 May 2004 Complete Application Filed

  Priority application(s): 10/319,915 12.12.02 US

19 August 2004 Application Open to Public Inspection

  Published as AU-A-2003300862

22 September 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003300863-Fabric softener compositions containing a mixture of cationic polymers as rheology modifiers

2003300861-METHOD OF DISPLAYING AN IMAGE CAPTURED BY A DIGITAL CAMERA